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SObjective: Esophageal anastomotic leaks, perforations, and fistulae are associated with considerable morbidity
and mortality. The aim of the present study was to assess the efficacy of self-expanding plastic stents in the treat-
ment of esophageal leaks.
Methods: From 2001 to 2009, 41 patients with postoperative anastomotic leaks (n ¼ 30), esophageal perfora-
tions (n ¼ 6), or fistulae (n ¼ 5) were treated by endoscopic insertion of self-expanding plastic stents. The
clinical outcome of the patients was analyzed, including leak healing, morbidity, and mortality.
Results: Self-expanding plastic stents were successfully inserted in all 41 patients without procedure-related
complications. Non-ventilated patients received oral feeding an average of 3.9 days after stent placement. Com-
plete leak healing was obtained in 27 of 30 patients (90%) with anastomotic leaks and 5 patients (83%) with
perforation. Sealing of fistulae by the stents was achieved in all 5 patients, and closure of the fistula was observed
in 2 patients (40%). The mean healing time was 30 days for anastomotic leaks, 15 days for esophageal perfo-
rations, and 16 days for fistulae. Stent migration occurred in 14 cases, but endoscopic reintervention and new
stent placement were successful in all cases. In-hospital mortality after treatment of esophageal leaks with stents
was 10%.
Conclusions: In combination with effective interventional or surgical drainage, stenting is a viable option for the
treatment of esophageal anastomotic leaks and perforations, but the success in tracheoesophageal fistula is
limited. (J Thorac Cardiovasc Surg 2011;141:1213-7)GThrough advances in surgical technique and adjuvant treat-
ment, the prognostic outcome of esophageal cancer has im-
proved, but anastomotic leaks after gastroesophageal
resections for cancer are still a therapeutic problem.1-3
Spontaneous ruptures or esophageal perforations after
endoscopic procedures are also potentially life-threatening
events. The most effective way to manage these complica-
tions remains controversial. In the past, aggressive surgical re-
exploration and conservative treatment with additional
drainage, total parenteral nutrition, nasogastric decompres-
sion, and broad-spectrum antibiotics have been associated
with considerable mortality rates (20%–40%), extensive in-
tensive care unit (ICU) stay, and lengthy hospitalization of pa-
tients.4-6 Modern surgical management of esophageal leaks
with early reoperation and primary anastomotic repair and
reinforcement of the anastomosis with muscle flaps results
in significantly lower mortality rates.7,8 Endoscopic
placement of self-expanding metal stents (SEMS) has beene Department of Surgery and Surgical Oncology,a Helios Hospital, Berlin,
any; and Department of General, Visceral and Transplantation Surgery,b
te Campus Virchow Hospital, University of Medicine, Berlin, Germany.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication April 24, 2010; revisions received June 29, 2010; accepted
blication July 11, 2010; available ahead of print Dec 17, 2010.
for reprints: Michael H€unerbein, MD, PhD, Department of Surgery and Sur-
Oncology, Helios Hospital Berlin, 13122 Berlin, Germany (E-mail: michael.
rbein@helios-kliniken.de).
23/$36.00
ht  2011 by The American Association for Thoracic Surgery
016/j.jtcvs.2010.07.096
The Journal of Thoracic and Carsuccessfully used for definitive palliative treatment of trache-
oesophageal fistulae caused by advanced mediastinal malig-
nancy or radiochemotherapy for esophageal cancer.9,10
However, there is only limited experience with temporary
stenting for the treatment of benign esophageal leaks, such
as anastomotic leakage and perforation.
This study evaluated the efficacy of self-expanding plas-
tic stents (SEPS) for the treatment of esophageal anasto-
motic leaks, esophageal perforations, and fistulae in
a group of 41 patients.
MATERIALS AND METHODS
Patients
From 2001 to 2009, SEPS were used in 41 patients for the treatment of
postoperative esophageal anastomotic leaks, esophageal perforations,
or tracheoesophageal or mediastinal fistulae. This analysis includes 30 pa-
tients from our hospital and 11 patients who were transferred from other
institutions. All leaks were diagnosed by esophagogastroscopy and a con-
trast study. Indication for stenting was limited to patients with leaks involv-
ing less than 30% of the esophageal circumference and without extensive
necrosis of the gastric conduit. Institutional review board approval was not
necessary because esophageal stenting was considered as a routine proce-
dure that was added to conservative treatment of esophageal leaks. There
were 32 male patients and 9 female patients with a mean age of 63 years
(range, 49–90 years). Postoperative anastomotic leaks occurred in 30 pa-
tients after abdomino-thoracic esophagectomy with an esophagogastric
(n ¼ 18) or esophago-colonic anastomosis (n ¼ 1), transhiatal resection
with an esophagogastrostomy (n ¼ 3), gastrectomy with esophagojejunos-
tomy in the lower mediastinum (n¼ 8), or resection of a diverticulum of the
esophagus (n ¼ 1). Three patients had a cervical leak, and 27 patients had
a thoracic leak. The interval between surgery and leak detection ranged
from 1 to 33 days (mean, 7.6 days). Esophageal perforations were observeddiovascular Surgery c Volume 141, Number 5 1213
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CT ¼ computed tomography
ICU ¼ intensive care unit
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SEPS ¼ self-expanding plastic stent
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Sin 6 patients after dilatation of malignant (n¼ 3) or benign stenoses (n¼ 2)
and as the result of vomiting (Boerhaave’s syndrome) in 1 patient. Trache-
oesophageal fistulae occurred in 3 patients after radiochemotherapy of
advanced esophageal cancer, but there was also 1 case with postoperative
anastomotic leakage. An esophago-pleural fistula after migration of
a gastric band and repeated surgery developed in 1 patient. The detailed
clinicopathologic data of the patients are shown in Table 1.
Stenting
All patients were treated by insertion of SEPS (Polyflex; Boston Scien-
tific, Natick, Mass). The Polyflex stent consists of an integral polyester
braid that is completely covered with a silicone membrane (proximal diam-
eter, 25 mm; body diameter, 21 mm; length, 12/15 cm). Only large stents
were used because smaller sizes have a higher tendency to migrate. Usually
the stent was placed immediately after the diagnosis of a leak was made by
endoscopy, but there was some delay in patients who were transferred from
other institutions. The mean interval from diagnosis of the leak to stent
placement was 2.7 days for anastomotic leaks, 3.2 days for esophageal per-
forations, and 2.2 days for esophageal fistulae. The stent was placed
immediately during index endoscopy in 25 patients, within 24 hours in
10 patients, and after more than 24 hours in 6 patients. Three patients
were initially treated with a covered SEMS before the plastic stent was im-
planted. Stent placement was performed under combined endoscopic and
fluoroscopic control. The details have been described.11 Briefly, all patients
received intravenous conscious sedation with 3 to 5 mg midazolam. By us-
ing a Seldinger technique, the stent was inserted into the esophagus with at
least a 3- to 4-cm overlap proximal and distal to the leak. Correct placement
of the stent and successful leak occlusion were confirmed by endoscopy
and contrast-enhanced fluoroscopy with a water-soluble contrast agent
(Figure 1). Oral intake was started with clear fluids the day after stent im-
plantation. If that was tolerated well, enteral nutrition was escalated in the
following days. Ventilated patients received a transnasal double-lumen
catheter for jejunal feeding and gastric drainage. Effectiveness of the treat-
ment was assessed by the quality of drainage fluids and clinical improve-
ment of the patient. Contrast-enhanced fluoroscopy or computed
tomography (CT) was performed if there was any doubt about effective
leak closure.
If necessary, additional chest tubeswere inserted viamini-thoracotomyor
interventional drainages were placed under CT guidance. In the initial pe-
riod, the stent was removed after 1 week to assess healing of the lesion
and exclude stent-related complications, but later the time was extended
to approximately 14 days. Complete closure of the leakwas confirmed endo-
scopically and by contrast-enhanced fluoroscopy (Figure 1). If there was ev-
idence of a residual leak, another stent was inserted and the procedure was
repeated 10 days later. Except in 1 postoperative case, stenting of tracheo-
esophageal fistula was considered as a definitive palliative treatment.
Data Analysis
Clinical data of patients and treatment were entered prospectively in
a database. This analysis includes all patients whowere treated by stenting.
In this group of patients, the exact number of patients who were treated
surgically or by stenting is unknown because some of the patients were
transferred from other institutions.1214 The Journal of Thoracic and Cardiovascular SurData for assessment of the efficacy of stent treatment included number
of stents required, time to oral intake, ventilatory support, time of ICU stay,
and time of hospital stay. Complications of stent implantation, such as mi-
gration, obstruction, and bleeding, were also recorded. Complete healing of
the leak, perforation, and fistula was assessed by esophagogastroscopy,
radiography with water-soluble contrast enhancement, and multislice
CT scan. All patients enrolled in the study were followed up in 3-month
intervals after SEPS removal.RESULTS
SEPS were successfully inserted in all 41 patients with
esophageal leaks. There was no technical failure in stent
placement. Except for stent migration, procedure-related
complications were not observed. Usually, it was no prob-
lem to reposition the stent endoscopically using a forceps.
In case of a leak associated with a stricture, a snare tech-
nique was used. The loop of the snare was placed around
the proximal end of the stent and tightened. The compressed
stent was then gently replaced over the leak.
There was no problem with pain or airway obstruction in
patients with proximal or mid-third esophageal stent place-
ment. A single stent was implanted in 27 patients with anas-
tomotic leak (90%), 5 patients with esophageal perforation
(83%), and 3 patients with esophageal fistula (60%). Over-
all repeated stenting was necessary in 38 of 41 patients.
In non-ventilated patients, the mean time to oral intake
was 3.0 days (range, 0–19 days).
Complete sealing of the leak immediately after stenting
was observed in 25 of 30 patients (84%) with anastomotic
leakage. In some patients with a gastric conduit (n ¼ 4) or
colonic conduit (n ¼ 1), there was backflow of contrast
around the stent in the reverse Trendelenburg position.
These patients were instructed to maintain an upright posi-
tion as much as possible. Healing of the anastomotic leak
without reoperation was achieved in 27 of 30 patients
(90%). Two patients with mediastinal leaks underwent re-
peat surgery with anastomotic repair because of persistent
leakage despite stent treatment. Both patients subsequently
died of persistent sepsis and multiorgan failure. Re-
thoracotomy was performed in 1 patient with a leak of an
esophago-colonic anastomosis because of stent dislocation
and inability to place new a stent. A new stent was placed
intraoperatively, and the leak healed after 19 days. Stent
treatment of perforations was successful in 5 of 6 patients
(83%). Two patients with esophageal cancer underwent cu-
rative esophagectomy after healing of the leak and regener-
ation. No further treatment was required in 3 patients with
benign perforations. One geriatric patient died of severe
sepsis resulting from pneumonia and residual mediastinitis.
In the group with fistula, there were 3 patients with ad-
vanced esophageal cancer in whom stenting was performed
as a definitive palliative treatment. As expected, control
bronchoscopy confirmed persistence of the fistula in all 3
patients until they died of progressive disease. However,
healing of the fistula was achieved in 2 patients (40%).gery c May 2011
TABLE 1. Clinicopathologic characteristics of 41 patients with
esophageal leaks, perforations, or fistulae
Patient
characteristics
Anastomotic leak
(n ¼ 30)
Esophageal
perforation (n ¼ 6)
Esophageal
fistula (n ¼ 5)
Age, y (range) 62 (50–77) 71 (51–90) 57 (49–72)
Gender
Male:female 24:6 5:1 3:2
Diagnosis
Cancer 29 4 4
Esophagus* 17* 2* 4
EGJ 6 2 0
Stomach 6 0 0
Benign 1y 2 1
Tumor type
AC 16 2 0
SCC* 5 1 4
GIST 1 0 0
EGJ, Esophago-gastric-junction; SCC, squamous cell cancer; AC, adenocarcinoma;
GIST, gastrointestinal stroma tumor. *Including 1 patient with GIST. yEsophageal
diverticulum.
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SOne patient with a tracheo-oesophageal fistula after esoph-
agectomy for esophageal cancer was successfully treated by
double stenting of the esophagus and the main bronchus.
The other patient had a chronic esophago-pleural fistula af-
ter removal of a penetrated gastric band.
The mean time to lesion healing in anastomotic leaks
(time to stent retrieval) was 30 days (Table 2). Stent migra-
tion was observed in 14 of 41 patients (35%). In all but 1
case, stent dislocation could be managed by re-stenting or
endoscopic repositioning of the stent. In addition to the
stent, perianastomotic or pleural drainage was obtained by
CT-guided drainage in 18 patients.FIGURE 1. Radiogram of a large esophageal diverticulum (A), leakage of the
closure of the leak by a stent (C), and healing of the leak without stenosis after
The Journal of Thoracic and CarThe general clinical outcome of the patients after stent-
ing, including ICU stay, hospital stay, and in-hospital mor-
tality, is shown in Table 2. In-hospital mortality was 10%
(pneumonia and severe sepsis in 4/41 patients). The mean
follow-up time is now 12.8 months (range, 1–61 months),
and 70% of the patients are still alive. A stricture developed
in 1 patient 6 months after successful treatment of esopha-
gogastric leakage caused by necrosis of the proximal gastric
tube after esophagectomy that required reoperation. Three
patients with leaks of esophagogastric anastomosis in the
neck underwent repeated endoscopic balloon dilations after
healing of the leak.DISCUSSION
Because of the considerable morbidity and mortality of
surgical and conservative treatment of esophageal leaks,
endoscopic procedures have been increasingly used as
aminimally invasive alternative. Endoscopic balloon dilata-
tion or clipping may be successful in the treatment of small
leaks, but the efficacy of both techniques is limited in larger
lesions.12 After the introduction of SEMS for palliative
treatment of advanced esophageal cancer, covered stents
have also been evaluated for sealing of esophageal leaks.
Stent insertion has become the treatment of choice for
esophagorespiratory fistula and is used as a definitive palli-
ative treatment without intention to remove the stent later.
High technical success rates for placement and sealing rates
of approximately 90% have been reported in the litera-
ture.13-15 However, long-term complications such as perfo-
ration and bleeding are well-known complications of
permanent stenting in esophageal cancer.16,17 Some of the
first-generation SEMS were difficult to remove becausestapler line after thoracoscopic resection of the diverticulum (B), complete
27 days of stent treatment (D).
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TABLE 2. Clinical results in 41 patients after self-expanding plastic
stent placement
Clinical results
Anastomotic
leak
(n ¼ 30)
Esophageal
perforation
(n ¼ 6)
Esophageal
fistula
(n ¼ 5)
ICU stay (d) 21 (0–79) 22 (0–91) 15 (0–63)
Hospital stay (d) 45 (9–115) 35 (9–91) 30 (6–63)
Other therapy
Reoperation* 3 (10%) 0 (0%) 0 (0%)
Interventional drainage 12 (29%) 5 (83%) 1 (20%)
Tracheotomy 13 (32%) 1 (17%) 1 (20%)
Time to oral Intake (d)y 2.7 (0–19) 3.2 (1–9) 2.2 (1–2)
Time to leak healing (d) 30 (7–62) 15 (6–26) 16 (13–19)
In-hospital mortality 2 (7%) 2 (17%) 0 (0%)
ICU, Intensive care unit. *For stent failure. yNon-ventilated patients. Values are mean
(range or percentage).
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Sthe uncovered ends of the stent become deeply embedded in
the esophageal wall.18,19 Completely covered SEMS and
silicone-covered SEPS have been developed to avoid this
problem.
The current study evaluated the results of SEPS stenting
in a group of 41 patients with esophageal leaks. Complete
healing of the leak was achieved in a high rate of patients
with anastomotic leakage (90%) and esophageal perfora-
tion (83%) after a mean treatment of 30 days and 15
days, respectively. The mortality in the anastomotic leak
group was 7%.
This rate is still higher than the mortality rate of 3.3% re-
ported in a large series of patients who underwent reopera-
tion with closure of intrathoracic leaks with muscle flaps.19
These data demonstrate that reoperation with surgical repair
remains a viable option for selective management of esoph-
ageal leak in specialized institutions.
In this study, the overall mortality rate after stent treat-
ment of esophageal leaks, perforations, and fistula was
10%. Most of those patients were transferred from other in-
stitutions and underwent delayed stenting. Patients died of
sepsis despite subsequent rethoracotomy with mediastinal
drainage. Immediate stenting after diagnosis of a leak seems
to be crucial to avoid further bacterial contamination of the
mediastinum.Our data suggest that temporary stenting is ef-
fective in the treatment of non-malignant esophageal leaks.
Similar results with high healing rates (80–90%) and low
mortality rates after treatment of anastomotic leaks or
esophageal perforations using covered stents have been re-
ported by other groups.20 Stent treatment may be not appro-
priate for extensive leaks, conduit necrosis, or cervical
leaks. In this series, there was only 1 patient with a limited
conduit necrosis who underwent stenting. Subsequent reop-
eration with colonic interposition was necessary because of
recurrent stenosis. A stenosis requiring endoscopic balloon
dilatation developed in 3 patients with cervical leaks.
Langer and colleagues21 observed a stenosis of the gas-
trojejunostomy in 2 of 7 patients after stent retrieval and1216 The Journal of Thoracic and Cardiovascular Surrecommend permanent stenting in patients with gastric
pull-up. In this series, stents were removed or changed
approximately 14 days after placement. This approach con-
trols healing of the leak and avoids perforations. Frequent
stent change, however, may undermine the cost advantages
of plastic stents. Although some mucosal ulcerations were
observed after 2 weeks, it seems reasonable to extend
the time to stent removal further to a mean healing time
of 30 days.
One problem with SEPS is the relatively high rate of stent
migration. In our study, dislocation of the stent occurred in
35% of the cases, which is similar to the rates reported
from other groups (10%–30%).22,23 The plastic stent is
characterized by a smooth surface that favors migration but
facilitates retrieval. This situation generally can be
managed by removal and exchange of the stent or
overstenting. The problem of stent migration and
incomplete sealing of big conduits may be solved by stents
with larger diameter. In the meantime, a completely
covered SEMS with a diameter of 3 cm has been developed
and seems to be promising.24
Nonetheless, stenting of anastomotic leaks after gastrec-
tomy should be done with caution because migration of the
stent can result in obstructive ileus and reoperation of the
patient. This problem was not observed in the current study.
One limitation of this study is that the results of stenting are
not compared with other treatments because some of the pa-
tients were transferred from other institutions. However,
a historical comparative study on treatment of esophageal
anastomotic leaks has been published.25 Intraluminal vac-
uum sponge therapy is a new method for management of
esophageal leaks.26 At present, the small number of treated
patients does not allow definite assessment of this experi-
mental therapy.CONCLUSIONS
The results of this study suggest that a brief period of
stenting with self-expanding covered stents is an effective
treatment for thoracic esophageal anastomotic leaks and
esophageal perforations. Patients with large leaks, conduit
necrosis, or cervical anastomosis are better treated surgi-
cally. Immediate stenting in combination with adequate
surgical drainage can avoid reoperation in selected patients
and reduce leak-related morbidity and mortality.References
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